Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 22 Leukemia 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Myelodysplastic Syndromes 17 Lymphoma 14 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12 Multiple Myeloma 10 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma, Non-Hodgkin 7 Leukemia, Biphenotypic, Acute 5 Hodgkin Disease 5 Hematologic Neoplasms 5 Hematologic Diseases 5 Neuroblastoma 4 Graft vs Host Disease 4 Sarcoma, Ewing 3 Rhabdomyosarcoma 3 Neoplasms, Plasma Cell 3 Neoplasms 3 Myeloproliferative Disorders 3 Lymphoma, Follicular 3 Leukemia, Myeloid 3 Leukemia, Lymphoid 3 Congenital Abnormalities 3 Burkitt Lymphoma 3 Brain Neoplasms 3 Wilms Tumor 2 Waldenstrom Macroglobulinemia 2 Testicular Neoplasms 2 Sarcoma 2

Interventions

Rituximab 4 Etoposide 4 Cyclophosphamide 4 Vincristine 3 Prednisone 3 Doxorubicin 3 liposomal doxorubicin 2 varlilumab 1 prednylidene 1 pomalidomide 1 fialuridine 1 etoposide phosphate 1 deltacortene 1 Vorinostat 1 Ultrasonography 1 Salvia hispanica seed extract 1 Peripheral Blood Stem Cell Transplantation 1 Nivolumab 1 Lenalidomide 1 Immunoglobulin G 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Endoscopy 1 Electrocardiography 1 Echocardiography 1 Disulfides 1 Cytarabine 1 Carmustine 1 CT-P10 1 Bronchoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Primary Effusion × Bone Marrow Transplantation × Clear all

NCT04975698 2026-03-25

BMTCTN1903

National Heart, Lung, and Blood Institute (NHLBI)

Phase 2 Completed

Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡